Gut Microbiota-induced Long Non-coding RNA Snhg9 Regulates the Development of Human Malignant Tumors

Dengke Jia1,2,3, Yaping He4, Qianle Chen1,2,3

  • 1Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, China.

PubMed

Insights

Gut microbes and long non-coding RNAs (lncRNAs) impact cancer progression. Specifically, lncRNA Snhg9 interacts with gut microbiota, influencing human malignant tumors and offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Microbiology
  • Molecular Biology

Background:

  • Gut microbes modulate cancer development via immune and metabolic pathways.
  • Long non-coding RNAs (lncRNAs) are implicated in cancer progression and are influenced by intestinal microbiota.
  • Specific lncRNA Snhg9 exhibits interactions with gut microorganisms relevant to human malignancies.

Purpose of the Study:

  • To investigate the intricate relationship between lncRNAs and intestinal flora in cancer.
  • To elucidate the regulatory mechanisms of lncRNA Snhg9 in the context of human malignant tumors.
  • To identify novel therapeutic targets for human cancers based on lncRNA-microbiota interactions.

Main Methods:

  • Literature review and analysis of existing research on lncRNAs, gut microbiota, and cancer.
  • Bioinformatic analysis to identify cross-talk between Snhg9 and microbial communities.
  • Molecular pathway analysis to understand the role of Snhg9 in tumor progression.

Main Results:

  • Established a significant cross-talk between lncRNA Snhg9 and intestinal microorganisms.
  • Demonstrated the involvement of Snhg9 in the progression of various human malignant tumors.
  • Highlighted the immune and metabolic influence of gut microbes on lncRNA expression and function.

Conclusions:

  • The interaction between lncRNA Snhg9 and gut microbiota is a critical factor in human cancer development.
  • Understanding these interactions provides a basis for developing novel cancer therapies.
  • Targeting the Snhg9-microbiota axis offers a promising avenue for future oncology research.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K